Contraceptive Drugs and Devices Market Report, Size, Development, Key Opportunity, Application and Forecast to 2027
The Global Contraceptive Drugs and Devices Market is expected to increase at a
higher rate by 2027 expanding at a reasonable CAGR during the forecast period
(2021-2027). Contraception is the use of various agents, drugs, devices, and
surgical procedures for the prevention of unwanted pregnancy.
For a detailed analysis of the Contraceptive Drugs and Devices Market browse
through https://univdatos.com/report/contraceptive-drugs-and-devices-market-current-analysis-and-forecast-2021-2027
A rise in the number of unintended
pregnancies, Sexually Transmitted Diseases (STD) cases, and increased Government
initiatives is driving the adoption and penetration of contraceptive drugs and devices
globally. Rising awareness regarding contraceptive pills further drives the
market growth. Female sterilization is the most common contraceptive method
used among women worldwide. In 2019, 23.7% or 219 million women are currently
using contraception. Male condom (189 million), IUD (159 million) and pill (151
million) were the other three majorly used method for the prevention of
unwanted pregnancy. A contraceptive pill or birth control pill mainly contains
hormones such as progestin and estrogen which block the release of eggs or ova
from the female ovaries. Hence, no fertilization occurs. There are several
benefits associated with contraceptive pills beyond the prevention of pregnancy
such as less pain, clear skin, prevention of ovarian cyst, and regular
menstrual cycle.
For a detailed analysis of the market drivers in Contraceptive Drugs and
Devices Market browse through
COVID-19 have a wide impact on Contraceptive
Drugs and Devices market growth. This is majorly due to the lack of access to
contraceptives. As per WHO, due to COVID-19, 7 in 10 countries have disrupted
health services in contraception and family planning. There is a huge
disruption in the manufacturing and supply chain of contraceptive pills which
is leading to a decline in the market growth. As per United Nations Population
Fund (UNFPA), there will be stock outs of various contraceptive drugs and devices
including oral contraceptive pills, condoms, copper intrauterine devices
(IUDs), and depot medroxyprogesterone acetate (DMPA).
For a
detailed analysis of the COVID-19 Impact on Contraceptive Drugs and Devices Market
browse through
Based on Products, the market is fragmented into Drugs and
Devices. Based on drugs the global Contraceptive drugs and devices market is bifurcated
into Oral Contraceptives, Topical Contraceptives and Contraceptive Injectable. Contraceptive
Devices are bifurcated into Condoms, Diaphragms, Cervical Caps, Sponges Vaginal Rings, and IUD. Within the Contraceptive drugs market, oral contraceptives
hold the major share due to their high efficacy, ease to intake, easy
availability, and inexpensive. In terms of Devices, condoms are
mainly used owing to increase cases of unwanted pregnancies, increase cases of
STDs, and an increase in initiatives taken by the government. Based on Gender,
the market is divided into Male and Female. The Male subsegment grabbed the
major market owing to the increase in commercialization of male birth control
Devices such as contraceptive injection for men. The female subsegment is also
expected to witness high growth owing to an increasing unwanted pregnancy.
For a
detailed analysis of the technology in Contraceptive Drugs and Devices Market browse
through
Based on the distribution channel,
the market is segmented into Hospital &
Clinics, Retail Pharmacy, Online Pharmacy, and Others. The retail pharmacy is
expected to be the fastest-growing market owing to an increase in
over-the-counter purchasing of contraceptive drugs. a detailed analysis was
conducted for different regions and countries including North
America (US, Canada, and the Rest of North America), Europe (Germany, France,
Italy, Spain, UK, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest
of APAC), Rest of World. In Eastern and South-Eastern Asia, IUD 18.6% is the
most common contraceptive method used, compared pill
17.8% and male condom 14.6% in the Europe and Northern America region.
Request for Sample of the report browses
through https://univdatos.com/report/contraceptive-drugs-and-devices-market-current-analysis-and-forecast-2021-2027
Some of the major players operating in the market include
Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Merck & Co.,
Inc., Mylan N.V., Allergan Plc, Agile Therapeutics, Piramal Enterprises Ltd.,
GlaxoSmithKline PLC, Johnson & Johnson, Novartis AG, and Sanofi, etc.
Several M&As along with partnerships have been undertaken by these players
to boost their presence in different regions.
Global Contraceptive Drugs and Devices Market Segmentation
Market Insight,
by Products
· By Drugs
o Oral Contraceptives
o Topical Contraceptives
o Contraceptive Injectable
·
By Devices
o Condoms
o Diaphragms
o Cervical Caps
o Sponges
o Vaginal Rings
o IUD
o Other Devices
Market Insight, by Gender
·
Male
·
Female
Market Insight, by Distribution Channel
·
Hospital & Clinics
·
Retail Pharmacy
·
Online Pharmacy
·
Others
Market Insight, by Region
·
North America Contraceptive
Drugs and Devices Market
o
United States
o
Canada
o
Rest of North America
·
Europe Contraceptive
Drugs and Devices Market
o
France
o
Germany
o
Italy
o
Spain
o
United Kingdom
o
Rest of Europe
·
Asia-Pacific Contraceptive
Drugs and Devices Market
o
China
o
Japan
o
India
o
Australia
o
Rest of Asia-Pacific
·
Rest of World Contraceptive
Drugs and Devices Market
Company Profiled
·
Bayer AG
·
Pfizer Inc.
·
Teva Pharmaceutical Industries Ltd.
·
Merck & Co., Inc.
·
Mylan N.V.
·
Allergan Plc
·
Agile Therapeutics
·
Piramal Enterprises Ltd.
·
GlaxoSmithKline PLC
·
Johnson & Johnson
·
Novartis AG
·
Sanofi
Labels: ceptive Drugs and Devices Market
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home